Clinical Trials Directory

Trials / Completed

CompletedNCT02420834

Dry Eye Treatment With Artificial Tears

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Aston University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dry eye is a chronic irritating eye condition that affects many people, caused by poor tear quality and insufficient quantity. Treatments are traditionally in the form of artificial tears applied to the ocular surface. However, there is little evidence in the scientific literature that demonstrates their efficacy relative compared to each other, nor how to decide which one might be most effective for an individual patient. Therefore the investigators aim to examine the efficacy of different classes of artificial tears (those designed to increase viscosity, reduce evaporation or to mimic the component balance of the natural tears). In addition, the investigators also aim to determine how the treatment preferred by an individual could potentially have been predicted from their baseline condition.

Detailed description

The efficacy of different classes of artificial tears (non-pharmaceutical) will be examined in patients that report dry eyes by prescribing each category of treatment \[0.40% Sodium Hyaluronate (Clinitas Soothe), 0.15% Sodium Hyaluronate (Hyabak), 0.25% Carboxymethylcellulose, electrolyte balanced (Theratears), and Phospholipid liposomal spray (Tears Again)\] for a month in turn following a short wash-out period and to examine their tear film and ocular surface after each one.

Conditions

Interventions

TypeNameDescription
OTHERHypromellose 0.15%Tear supplement to be taken as required to relieve symptoms
OTHERHypromellose 0.4%Tear supplement to be taken as required to relieve symptoms
OTHERCarboxymethylcelluloseTear supplement to be taken as required to relieve symptoms
OTHERLiposomal SprayTear supplement o be taken as required to relieve symptoms

Timeline

Start date
2015-04-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2015-04-20
Last updated
2019-01-10

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02420834. Inclusion in this directory is not an endorsement.